Savara Pharma News and Activities

Presence

Savara Pharma develops medicines for rare respiratory diseases. Its main products are inhaled drug candidates and related clinical programs for patients with serious lung conditions and the healthcare providers who treat them.

Savara Pharma products and services overview:

Respiratory therapies
Inhaled medicines
Rare disease drugs
Drug development

Revenue: ~$0 million

Employees: 90

Headquarters: Langhorne, United States (USA)

Savara Pharma is one of the...

Savara Pharma is a company listed under the stock ticker SVRA (US).

Executives

View the org chart displaying its 17 main executives

Most searched biographies at Savara Pharma

Popular executive movements at Savara Pharma

Rob Lutz, who was Chief Operating Officer, is promoted to Chief Financial Officer and Chief Operating Officer (posted on June 9 2026).
Dave Lowrance, Chief Financial and Administrative Officer, will leave the company on Jul. 15, 2026 (posted on June 9 2026).
Yasmine Wasfi, who was Senior Vice President and Head of Clinical Development, is promoted to Chief Medical Officer (posted on October 17 2025).

Create your alert
to follow the executive moves at Savara Pharma.